These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10387809)

  • 1. A framework for incorporating cost-effectiveness in evidence-based clinical practice guidelines.
    Mason J; Eccles M; Freemantle N; Drummond M
    Health Policy; 1999 Apr; 47(1):37-52. PubMed ID: 10387809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to develop cost-conscious guidelines.
    Eccles M; Mason J
    Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating economic analysis in evidence-based guidelines for mental health: the profile approach.
    Mason J; Eccles M; Freemantle N; Drummond M
    J Ment Health Policy Econ; 1999 Mar; 2(1):13-19. PubMed ID: 11967403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing valid cost effectiveness guidelines: a methodological report from the north of England evidence based guideline development project.
    Eccles M; Mason J; Freemantle N
    Qual Health Care; 2000 Jun; 9(2):127-32. PubMed ID: 11067251
    [No Abstract]   [Full Text] [Related]  

  • 5. Incorporating considerations of cost-effectiveness, affordability, and resource implications in guideline development: article 6 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Hill SR; Olson LG; Falck-Ytter Y; Cruz AA; Atkins D; Baumann M; Jaeschke R; Woitalla T; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):251-5. PubMed ID: 23256167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of the NET intervention versus guideline dissemination for management of mild head injury in hospital emergency departments.
    Mortimer D; Bosch M; Mckenzie JE; Turner S; Chau M; Ponsford JL; Knott JC; Gruen RL; Green SE
    Implement Sci; 2018 Dec; 13(1):147. PubMed ID: 30518430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piloting the development of a cost-effective evidence-informed clinical pathway: managing hypertension in Jordanian primary care.
    Chalkidou K; Lord J; Obeidat NA; Alabbadi IA; Stanley AG; Bader R; Momani A; O'Mahony RM; Qatami L; Cutler D
    Int J Technol Assess Health Care; 2011 Apr; 27(2):151-8. PubMed ID: 21473813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Clinical Guideline Centre cost-effectiveness assessment for the National Institute for Health and Clinical Excellence.
    Wonderling D; Sawyer L; Fenu E; Lovibond K; Laramée P
    Ann Intern Med; 2011 Jun; 154(11):758-65. PubMed ID: 21646559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifaceted implementation of stroke prevention guidelines in primary care: cluster-randomised evaluation of clinical and cost effectiveness.
    Wright J; Bibby J; Eastham J; Harrison S; McGeorge M; Patterson C; Price N; Russell D; Russell I; Small N; Walsh M; Young J
    Qual Saf Health Care; 2007 Feb; 16(1):51-9. PubMed ID: 17301206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities and limits of guidelines in medicine].
    Lauterbach KW
    Z Arztl Fortbild Qualitatssich; 1998 Mar; 92(2):99-105. PubMed ID: 9577897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the use of research evidence in guideline development: 11. Incorporating considerations of cost-effectiveness, affordability and resource implications.
    Edejer TT
    Health Res Policy Syst; 2006 Dec; 4():23. PubMed ID: 17147813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure.
    Eccles M; Freemantle N; Mason J
    BMJ; 1998 May; 316(7141):1369-75. PubMed ID: 9563995
    [No Abstract]   [Full Text] [Related]  

  • 15. Most guideline organizations lack explicit guidance in how to incorporate cost considerations.
    Sanabria AJ; Kotzeva A; Selva Olid A; Pequeño S; Vernooij RWM; Martínez García L; Zhang Y; Solà I; Thornton J; Alonso-Coello P
    J Clin Epidemiol; 2019 Dec; 116():72-83. PubMed ID: 31430507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care.
    Eccles M; Freemantle N; Mason J
    BMJ; 1998 Apr; 316(7139):1232-5. PubMed ID: 9553004
    [No Abstract]   [Full Text] [Related]  

  • 17. The limited incorporation of economic analyses in clinical practice guidelines.
    Wallace JF; Weingarten SR; Chiou CF; Henning JM; Hohlbauch AA; Richards MS; Herzog NS; Lewensztain LS; Ofman JJ
    J Gen Intern Med; 2002 Mar; 17(3):210-20. PubMed ID: 11929508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Ramaekers BLT; Wolff RF; Pouwels X; Oosterhoff M; Van Giessen A; Worthy G; Noake C; Armstrong N; Kleijnen J; Joore MA
    Pharmacoeconomics; 2018 Aug; 36(8):917-927. PubMed ID: 29480455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services.
    Saha S; Hoerger TJ; Pignone MP; Teutsch SM; Helfand M; Mandelblatt JS;
    Am J Prev Med; 2001 Apr; 20(3 Suppl):36-43. PubMed ID: 11306230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.